There are 141 new cases of COVID-19 to report in Saskatchewan on May 19, bringing the provincial total to 44,982 cases. There are four new COVID cases in the Weyburn area, with 25 active cases in the area, and 143 active cases for the southeast region.
The new cases are located in the following zones: Far North West, 5; Far North East, 1; Northwest, 19; North Central, 13; Northeast, 1; Saskatoon, 38; Central West, 4; Central East, 15; Regina, 18; Southwest, 3; South Central, 7; and Southeast, 9. Eight cases are pending residence information. Three cases with pending residence information have been assigned to the North West, 1; and Regina, 2.
The Graduation guidelines have been updated and provide additional options for graduates this spring. Step One of the Saskatchewan Re-Opening Roadmap permits up to 150 people at public outdoor gatherings.
As a result, beginning May 30, outdoor graduations may have up to 150 people, including graduates and guests. Teachers and school staff required to host the event are not included in the total. In Step Two, indoor and outdoor graduations will permit up to 150 people, including graduates and guests. No definite date has been determined for Step Two.
Recoveries total 42,674, including 180 new recoveries as of May 19, and 1,786 cases are considered active.
There are 134 people in hospital, and 106 people are receiving inpatient care: Northwest, 6; North Central, 5; Saskatoon, 42; Central East, 5; Regina, 42; Southwest, 2; South Central, 2; and Southeast, 2. Twenty-eight people are in intensive care: North Central, 2; Saskatoon, 10; and Regina, 16.
The seven-day average of new COVID-19 case number is 180 (14.7 new cases per 100,000).
There were 2,866 COVID-19 tests processed in Saskatchewan on May 18, including 126 tests in the southeast region.
An additional 6,935 doses of COVID-19 vaccine have been given in Saskatchewan, bringing the total number of vaccines administered in the province to 615,459. There were 500 doses administered in the southeast region.
Seventy-five per cent of those over the age of 40 have received their first dose. Sixty-eight per cent of those 30+ have received their first dose. Sixty per cent of those 18+ have received their first dose.
